These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8032872)

  • 1. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells.
    Yoshii M; Watabe S
    Brain Res; 1994 Apr; 642(1-2):123-31. PubMed ID: 8032872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
    Zhao X; Kuryatov A; Lindstrom JM; Yeh JZ; Narahashi T
    Mol Pharmacol; 2001 Apr; 59(4):674-83. PubMed ID: 11259610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels.
    Yoshii M; Watabe S; Murashima YL; Nukada T; Shiotani T
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S95-102. PubMed ID: 10850736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam.
    Oyaizu M; Narahashi T
    Brain Res; 1999 Mar; 822(1-2):72-9. PubMed ID: 10082885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384).
    Yoshii M; Watabe S; Sakurai T; Shiotani T
    Behav Brain Res; 1997 Feb; 83(1-2):185-8. PubMed ID: 9062681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons.
    Huang CS; Ma JY; Marszalec W; Narahashi T
    Neuropharmacology; 1996; 35(9-10):1251-61. PubMed ID: 9014140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways].
    Yoshii M; Nishizaki T; Watabe S
    Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():41P-43P. PubMed ID: 10190131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
    Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
    J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors.
    Zhao X; Yeh JZ; Narahashi T
    Ann N Y Acad Sci; 2001 Jun; 939():179-86. PubMed ID: 11462769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor activation modulates Ca2+ channels in rat intracardiac neurons via a PTX- and voltage-sensitive pathway.
    Jeong SW; Wurster RD
    J Neurophysiol; 1997 Sep; 78(3):1476-90. PubMed ID: 9310437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin inhibition of N- and L-type calcium channel currents in NG108-15 cells.
    Connor M; Henderson G
    Neuropharmacology; 1997 Jan; 36(1):115-24. PubMed ID: 9144648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation- and voltage-dependent inhibition of neuronal calcium currents by activation of human D2(short) dopamine receptors.
    Brown NA; Seabrook GR
    Br J Pharmacol; 1995 Jun; 115(3):459-66. PubMed ID: 7582457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam.
    Yoshii M; Furukawa T; Ogihara Y; Watabe S; Shiotani T; Ishikawa Y; Nishimura M; Nukada T
    Ann N Y Acad Sci; 2004 Oct; 1025():389-97. PubMed ID: 15542741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of serotonin on caudal raphe neurons: inhibition of N- and P/Q-type calcium channels and the afterhyperpolarization.
    Bayliss DA; Li YW; Talley EM
    J Neurophysiol; 1997 Mar; 77(3):1362-74. PubMed ID: 9084603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiracetam on scopolamine-induced impairment of performance in a passive avoidance task.
    Yamada K; Nakayama S; Shiotani T; Hasegawa T; Nabeshima T
    J Pharmacol Exp Ther; 1994 Sep; 270(3):881-92. PubMed ID: 7932200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M4 muscarinic receptor activation modulates calcium channel currents in rat intracardiac neurons.
    Cuevas J; Adams DJ
    J Neurophysiol; 1997 Oct; 78(4):1903-12. PubMed ID: 9325359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Ca(2+)-channel currents by protein kinase C in adult rat sympathetic neurons.
    Zhu Y; Ikeda SR
    J Neurophysiol; 1994 Oct; 72(4):1549-60. PubMed ID: 7823085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reduction of neuronal calcium currents by ATP-gamma-S is mediated by a G protein and occurs independently of cyclic AMP-dependent protein kinase.
    Gross RA; Uhler MD; Macdonald RL
    Brain Res; 1990 Dec; 535(2):214-20. PubMed ID: 1963568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
    Moriguchi S; Shioda N; Han F; Narahashi T; Fukunaga K
    J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
    Nomura T; Nishizaki T
    Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.